Home » Topics » BioWorld Science

BioWorld Science
RSS

Cybin IRL describes new 5-HT2 receptor agonists

March 15, 2022

Novel antibacterials synthesized at the University of Jordan

March 15, 2022

New psilocin prodrugs discovered at Compass Pathfinder

March 15, 2022

Council of Scientific and Industrial Research patents nigericin derivatives

March 15, 2022

1st Bio Therapeutics identifies new ABL/LRRK2/LRRK2 mutant/RIPK2 inhibitors

March 15, 2022

2-Benzyllawsone shown to protect mice against polymicrobial sepsis

March 15, 2022

Bright Minds' BMB-101 for Dravet syndrome completes 28-day repeat toxicity studies

March 14, 2022

Del-1 potentiates BCI efficacy by blockade of tumor-infiltrating neutrophils

March 14, 2022

Discovery of novel MDM2 inhibitor with antitumor activity in p53 wild-type cancer models

March 14, 2022

FDA grants orphan drug designation to HT-KIT for mastocytosis

March 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...